Status:
COMPLETED
Regeneration of Liver: Portal Vein Embolization Versus Radiofrequency Assisted Ligation for Liver Hypertrophy (REBIRTH)
Lead Sponsor:
Imperial College London
Conditions:
Liver Resection
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to compare two different techniques (portal vein embolization and radiofrequency assisted liver partition with portal vein ligation) for increasing liver volume prior to major...
Detailed Description
Liver resection remains the gold standard treatment for patients with liver tumours providing them the only chance for long-term survival. In up to 45% of cases that are amenable to surgical resection...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Any patient requiring right or extended right hepatectomy with FLRV less than 25% on preoperative volumetric study
- WHO performance status 0, 1 or 2
- Patient able to comply with protocol requirements and deemed fit for surgical resection
- Written informed consent
Exclusion
- Inability to give informed consent
- Pregnancy
- WHO status 3 or 4
- New York Heart Association Classification Grade III or IV
Key Trial Info
Start Date :
July 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2018
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT02216773
Start Date
July 1 2015
End Date
April 1 2018
Last Update
November 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hammersmith Hospital
London, United Kingdom, W12 0HS